Jinhe Biotechnology Co.Ltd(002688) : annual report for 2021

Jinhe Biotechnology Co.Ltd(002688)

Annual report for 2021

April 2022

Section I important tips, contents and definitions

The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.

Wang Dongxiao, the person in charge of the company, Niu Youshan, the person in charge of accounting, and Zhou Lihang, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.

All directors have attended the meeting of the board of directors to consider this report.

1. Risks of rising prices of raw materials and energy

The raw material of the company’s main product aureomycin is corn starch, which accounts for a large proportion of the cost of aureomycin. The rise of corn price has a great impact on the cost of aureomycin products of the company. At the same time, the sharp rise in coal prices will also increase the production cost of the company’s chemical products and reduce the profit margin of the products.

2. Exchange rate risk

The company’s assets denominated in US dollars and the company’s overseas sales revenue are related to exchange rate fluctuations, so exchange rate fluctuations will affect the company’s performance.

3. Market risk

Affected by the pig cycle, the breeding industry continues to be depressed. As an upstream industry of the breeding industry, the company’s animal insurance business is bound to be affected by it. Therefore, there is a risk that the market does not meet expectations.

4. R & D risk

The company continues to invest in vaccine product research and development. Vaccine product research and development cycle is long, investment is large, technology is complex, and there is a risk of uncertainty in the research and development results.

The company’s profit distribution plan reviewed and approved by the board of directors is: take 780422398 as the base, distribute cash dividend of 0.00 yuan (tax included) to all shareholders for every 10 shares, send bonus shares of 0 share (tax included), and do not use the accumulation fund to increase the share capital.

catalogue

Section I important tips, contents and definitions Section 2 company profile and main financial indicators Section III discussion with management Section IV corporate governance 48 Section V environmental and social responsibility 73 section VI important matters 79 Section VII changes in shares and shareholders Section VIII preferred shares 103 section IX relevant information of bonds 104 section x financial report one hundred and five

Directory of documents for future reference

1、 The original of the 2021 annual report signed and confirmed by the directors, supervisors and senior managers of the company. 2、 Financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting work and the person in charge of accounting organization (Accounting Supervisor). 3、 The original of the audit report with the seal of ShineWing Certified Public Accountants (special general partnership) and the signature and seal of the certified public accountant. 4、 The originals of all company documents and announcements publicly disclosed on the website designated by the CSRC during the reporting period. 5、 The place where the above documents for future reference are prepared: the Securities Department of the company and Shenzhen Stock Exchange.

interpretation

Explanatory item refers to the explanatory content

The company, the company, the joint stock company, Jinhe Biotechnology Co.Ltd(002688) refers to Jinhe Biotechnology Co.Ltd(002688)

Jinhe holding refers to Inner Mongolia Jinhe Holding Co., Ltd

Jian’an company and Jinhe Jian’an refer to Inner Mongolia Jinhe construction and installation Co., Ltd

Starch company and Jinhe starch refer to Inner Mongolia Jinhe Starch Co., Ltd

Animal pharmaceutical and Jinhe animal pharmaceutical refer to Inner Mongolia Jinhe Animal Pharmaceutical Co., Ltd

Jinhe pharmaceutical refers to Inner Mongolia Jinhe Pharmaceutical Technology Co., Ltd

Jinhe environmental protection and environmental protection company refers to Inner Mongolia Jinhe Environmental Protection Technology Co., Ltd

Jinhe Youben company refers to Jinhe Youben Biological Products Co., Ltd

Farmaway means farmgate Inc

Hangzhou Youben refers to Hangzhou Youben animal vaccine Co., Ltd

Hohhot Youben vaccine technology Co., Ltd

Putek, famavir biological products and biologics refer to protatek international, Inc., famavir Jinyu Bio-Technology Co.Ltd(600201) Co., Ltd., pharmgate Inc. biologics Inc. and protatek International Biologics Inc.

Animal nutrition company refers to Inner Mongolia Jinhe Animal Nutrition Technology Co., Ltd

Muxing Chongqing refers to Jinhe muxing (Chongqing) Biotechnology Co., Ltd

Jining environmental protection refers to Jining Jinhe Environmental Protection Technology Co., Ltd

Kodiago means coldiagro

Solid waste disposal refers to Tuoketuo Jinhe environmental protection solid waste disposal Co., Ltd

Liangshan Ruyi refers to Liangshan Ruyi Yellow River Beach sewage treatment Co., Ltd

Zhaqi water and Jinhe water refer to zhalai banner Jinhe water Co., Ltd

Jinhe reclaimed water company refers to Tuoketuo Jinhe environmental protection reclaimed water resources Co., Ltd

Penfield refers to Penfield oil company

CSRC refers to the China Securities Regulatory Commission

Shenzhen stock exchange refers to Shenzhen Stock Exchange

A share refers to RMB ordinary shares

Company Law refers to the company law of the people’s Republic of China

Securities Law refers to the securities law of the people’s Republic of China

The articles of association refers to the Jinhe Biotechnology Co.Ltd(002688) articles of association

GMP refers to the good manufacturing practice

FDA refers to the abbreviation of U.S. Food and drug administration, namely the U.S. Food and drug administration

The reporting period refers to 2021

Section II Company Profile and main financial indicators

1、 Company information

Stock abbreviation Jinhe Biotechnology Co.Ltd(002688) stock code Jinhe Biotechnology Co.Ltd(002688)

Shenzhen Stock Exchange

Chinese name of the company Jinhe Biotechnology Co.Ltd(002688)

Chinese abbreviation of the company Jinhe Biotechnology Co.Ltd(002688)

Foreign language name of the company (if any) Jinhe Biotechnology Co., Ltd

Abbreviation of the company’s foreign name (e.g

Yes) Jinhe Biotechnology

Legal representative of the company: Wang Dongxiao

Registered address: No. 71, Xinping Road, Tuoketuo County, Inner Mongolia Autonomous Region

Postal code of registered address 010200

Historical change of registered address of the company

nothing

condition

Office address: No. 71, Xinping Road, Tuoketuo County, Inner Mongolia Autonomous Region

Postal code of office address 010200

Company website: www.jinhe.com com. cn.

E-mail [email protected].

2、 Contact person and contact information

Secretary of the board of directors and securities affairs representative

Name has a long way to go

Contact address: 84 Xing’an North Road, Xincheng District, Hohhot, Inner Mongolia

22 / F, dingshenghua Century Plaza office building

Tel: 04713291630

Fax 04713291625

E-mail [email protected].

3、 Information disclosure and preparation location

The website of the stock exchange on which the company discloses the annual report includes Securities Daily, securities times, China Securities News and Shanghai Securities News

Media name and website of the annual report disclosed by the company http://www.cn.info.com.cn.

The company’s annual report is prepared at the company’s securities department and Shenzhen Stock Exchange

4、 Registration changes

Organization code unified social credit code 9115 Shenzhen Properties & Resources Development (Group) Ltd(000011) 4368372k

Changes in the company’s main business since its listing (for example, in 2015, the company added a new business scope: production of additive premixed feed (vitamin premixed feed) (livestock, poultry and aquatic products, ruminants, pets and special animals); In 2018, the company added a new business scope: the production of oxytetracycline calcium premix, feed raw materials and mixed feed additives.

Changes of previous controlling shareholders (if any) on July 16, 2021, the controlling shareholder of the company was changed from Jinhe Jian’an to Jinhe holding.

5、 Other relevant information: accounting firm employed by the company

Name of accounting firm: ShineWing Certified Public Accountants (special general partnership)

Office address of the accounting firm: 8 / F, building a, Fuhua building, No. 8, Chaoyangmen North Street, Dongcheng District, Beijing

Name of signature accountant: Zhai Xiaomin, Shi Zhouhong

Recommendation agencies hired by the company to perform continuous supervision duties during the reporting period √ applicable □ not applicable

Name of recommendation institution office address of recommendation institution name of recommendation representative during continuous supervision

Orient Securities Company Limited(600958) underwriting and recommendation Co., Ltd. Han Yang and Huang Jian, 318 south Zhongshan Road, Huangpu District, Shanghai August 2021 December 31, 2022, 24th floor

Those employed by the company to perform continuous supervision duties during the reporting period

- Advertisment -